Abstract-The effect of histamine administered to the brain on the plasma levels of epinephrine, norepinephrine and glucose was investigated in freely moving rats. Histamine (10 jig) administered intracerebroventricularly (into the lateral ventricle) induced a hyperglycemic response with preceding increases in plasma catechol amines, especially epinephrine.
Abstract-The effect of histamine administered to the brain on the plasma levels of epinephrine, norepinephrine and glucose was investigated in freely moving rats. Histamine (10 jig) administered intracerebroventricularly (into the lateral ventricle) induced a hyperglycemic response with preceding increases in plasma catechol amines, especially epinephrine.
When histamine (5 iig) was injected into three different levels of the ventricular system, the magnitude and duration of the resulting increases in plasma epinephrine and glucose were in the following rank order: the third ventricle>aqueduct>>fourth ventricle. These results suggest that the sites of action of histamine are located rostrally from the midbrain.
Microinjections of histamine (1 /tg) into the hypothalamic nuclei including the medial preoptic area, paraventricular nucleus, ventromedial hypothalamic nucleus, posterior hypothalamic nucleus and mammillary body had no elevating effect on the plasma levels of epinephrine and glucose.
Other brain regions, such as the lateral septum, medial amygdaloid nucleus and periaqueductal grey of the midbrain, were also excluded as possible sites of histamine action.
From the present results, it seems that hista mine stimulates plural sites close to the ventricular system to induce hyperglycemic responses.
There is considerable evidence that hista mine may act as a neurotransmitter or a neu romodulator in the CNS (1-3). The histamine content (4, 5) , the histidine decarboxylase ac tivity (4) , and the turnover rate of histamine (6) (7) (8) are highest in the hypothalamus, and histaminergic neurons have been suggested to be involved in vegetative functions of the hypothalamus (2). Donoso and Barontini (9) observed in creases in plasma catecholamines after intra cerebroventricular (i.c.v.) injection of hista mine in rats and suggested a role for histamine in the central regulation of cardiovascular functions. In a previous study, we demon strated that the i.c.v. injection of histamine in mice induced hyperglycemia via H~-receptors, which was markedly inhibited by bilateral To whom all correspondence and reprint requests should be addressed. adrenalectomy and abolished by a and (3 blockers administered systemically and simul taneously (10) . These results suggest that the stimulation of Hi-receptors in the brain activates the sympatho-adrenomedullary axis, and the resulting increased secretion of catecholamines from the adrenal medulla eventually leads to the elevation of plasma glucose levels.
In the present study, we tried to determine the sites of action of histamine for this re sponse by examining the changes in the plasma levels of epinephrine, norepinephrine and glucose after the injection of histamine into different parts of the ventricular system of the brain or different brain regions of freely moving rats.
Materials and Methods

Animals:
Male Sprague-Dawley rats weighing 250-300 g (Seiwa Experimental
Animals, Fukuoka, Japan) were housed in a room controlled at 22*2°C on a 12-hr light dark cycle (light period, 6:00 A.M. -6:00 P.M.). Food and water were provided ad libitum.
General procedure: The rats were anesthe tized with sodium pentobarbital (50 mg/kg, i.p.) and placed on a stereotaxic device for the implantation of cannulas. The stainless steel guide cannulas (23 gauge) were inserted through the skull according to the atlas of Paxinos and Watson (11) . The tips of the guide cannulas were positioned 1.5 mm above the injection sites, and the cannulas were fixed to the skull with dental acrylic and screws. The stereotaxic coordinates from bregma were as follows: for the medial pre optic area, AP -0. cannulas, the rats were handled twice a day for 7 days before the experiments to acclimate them to this procedure. One or two days prior to each experiment, an indwelling catheter (SP-45) was inserted into the right carotid artery. The tubing was led under the skin to the back and sewed to the skin. The tubing was filled with 0.9% NaCI solution containing heparin (500 U/ml). On the day of the experi ment, a polyethylene tube extension was con nected to the catheter from which the blood samples were withdrawn under freely moving conditions. The dead space in the catheter was 100 ,ul. After the sampling of blood (0.5 ml), an equal volume of heparinized saline was returned to the animals. The blood samples were transferred immediately to pre chilled tubes and stored on ice until further processing. The samples were then centri fuged at 650xg for 10 min, and the plasma were used for the assay of catecholamines and glucose.
For the microinjection of saline or histamine solution, the injection cannula connected via polyethylene tubing to a Hamilton micro syringe was inserted through the guide cannula, and 5 /I (i.c.v. Injection) or 1 /el (injection into hypothalamic or other brain regions) was injected over a period of one minute. For the microinjection, histamine dihydrochloride was dissolved in saline and the pH was adjusted to 7.0 with 0.1 N NaOH, maintaining the isotonicity.
After the experiments, the injected sites were confirmed by the injection of methylene blue dye. Furthermore, Nissle staining was performed for confirming the presence of the cannula in the proper brain regions. For this purpose, rats were anesthetized with sodium pentobarbital and perfused transcardially with 100 ml of saline followed by 200 ml of 10% formalin in 0.1 M phosphate buffer, pH 7.0. Brains were removed, stored in 30% sucrose in 10% formalin overnight, sectioned (50 ,em) on a freezing microtome and stained. Rats exhibiting extensive bleeding were omitted.
Determination of epinephrine and nor epinephrine:
Plasma epinephrine and nor epinephrine were adsorbed onto alumina and determined by a modification of the method of Refshauge et al. (12) , using HPLC with electrochemical detection. Briefly, to each plasma sample (250 /fl) was added 2 ml of 0.4 N perchloric acid containing 0.1% Na2 EDTA, 0.05% Na2S2O5 and an appropriate amount of 3,4-dihydroxybenzylamine as an internal standard. After centrifugation, 200 ,al of 2 M Tris-HCI buffer (pH 8.3) was added to the supernatant, and the pH was adjusted to 8.3 with 5 N NaOH. The samples were then mixed with 50 mg of alumina and the alumina was washed four times with distilled water. The amines were eluted from the alumina by mixing with 200 iI of 0.1 N HCI. After cen trifugation, an 80-,I aliquot of the superna tant was applied to the chromatograph. The H PLC system was composed of a L-5000 pump (Yanagimoto MFG, Co., Kyoto, Japan), a voltametric detector (YM D 101A, Yanagi moto MFG, Co.) with a graphite working electorde operated at 700 mV vs. an Ag-AgCI reference electrode (Eicom, Kyoto), and a reverse-phase column (Chemcosorb ODS H, 5 gem, 150X4 mm; Chemco, Osaka, Japan). The mobile phase was 0.1 M KH2PO4 con taining 1.4 mM sodium octanesulfonate, 10 pM Na2EDTA and 30 mI/I of methanol, pH 3.1. Determination of glucose: Plasma glucose was assayed colorimetrically, using an o toluidine-borate method (13), with a slight modification (10) .
Drugs: Histamine dihydrochloride and ( epinephrine bitartrate were obtained from Nacalai Tesque (Kyoto, Japan); I-norepi nephrine hydrochloride and 3,4-dihydroxy benzylamine hydrobromide were from Sigma Chemical Co. (St. Louis, MO). All other chemicals used were of a guaranteed reagent grade.
Statistical analysis: The data were evaluated for statistical significance by one-way analysis of variance followed by Dunnett's test. A P value of less than 0.05 was con sidered significant. (Fig. 1) . The glucose level 5 min after the injection was already significantly higher than the preinjection level. The increase was most marked 15 min after the injection, and the glucose levels gradually decreased thereafter. The time course of the hyper glycemic response was similar to that ob tained in mice (10) . The glucose levels were not significantly changed by the injection of saline.
Results
I.c.v. (into the lateral ventricle) injection of histamine (10 ag) induced a hyperglycemic response
The plasma epinephrine levels in the hista mine-injected animals increased sharply to a peak value of about 8-fold the preinjection level observed 5 min after injection and then decreases slowly; the level at 90 min after in jection was not significantly different from the preinjection value. The norepinephrine levels were significantly higher than the preinjection value 5 min after the administration.
However, the increase in plasma norepinephrine was much smaller than that in plasma epinephrine, and the peak value at 5 min after injection was only about 1.5-fold the preinjection value (Fig. 2) . of the ventricular system on the plasma glucose and catecholamine levels, respec tively. When histamine was injected into the third ventricle, the hyperglycemic response continued for 30 min. Significant elevation of plasma epinephrine was observed until 15 min after injection. When histamine was in jected into the aqueduct of the midbrain, the magnitude of increases in the glucose and epinephrine levels was much smaller than that of increases induced by the injection into the third ventricle. No significant elevation of plasma epinephrine and glucose levels was observed after the administration of histamine into the fourth ventricle. The rise in plasma norepinephrine did not reach a significant level irrespective of the histamine injection site.
As shown in Table 1 , when injected into the medial preoptic area, paraventricular nucleus, ventromedial hypothalamic nucleus, posterior hypothalamic nucleus and mammil lary body, histamine (1 #g) was ineffective in producing hyperglycemic responses or signifi cant changes in plasma catecholamine levels. Bilateral injection of histamine (0.5 dig per each side) into the brain regions as described above was also ineffective (data not shown).
The injection of histamine (1 ,ag) into the lateral septum, medial nucleus of the amyg dala and periaqueductal gray of the midbrain also produced no elevation of plasma glucose or catecholamine levels (data not shown). 
Discussion
In the present study, histamine adminis tered i.c.v. produced hyperglycemic responses with a preceding elevation of plasma epi nephrine and norepinephrine levels in freely moving rats.
Donoso and Barontini (9) also determined the catecholamine levels 5 and 15 min after the administration of histamine into the third ventricle. They observed that the epinephrine levels were higher at 15 min than at 5 min after injection. However, in the present study, plasma epinephrine reached a peak 5 min after the administration of the same dose of histamine (5 fig) . The basal epinephrine levels in their study were relatively high, and this may be a reason for the different patterns of epinephrine elevation observed by the two groups.
Administration of histamine into different parts of the ventricular system revealed that the intensity of histamine-induced elevation of plasma epinephrine and glucose decreased as the injection site moved from the rostral to the caudal side of the system. This suggests that the major sites of action of histamine are located above the level of the midbrain. The hypothalamic nuclei are assumed to be closely related to the central regulation of autonomic functions and are rich in histaminergic fibers (14) and H~-receptors (15) . Moreover, it was also reported that the level of 3H-histamine was highest in the hypothalamus among the brain regions, when determined 5 min after the administration of 3H-histamine into the lateral ventricle (16) . Therefore, we performed microinjections of histamine into the hy pothalamic nuclei. However, no marked response was observed by injecting histamine into the medial preptic area, paraventricular nucleus, ventromedial hypothalamic nucleus, posterior hypothalamic nucleus or mammillary body.
It was reported that the microinjection of histamine into the posterior hypothalamus of urethane-anesthetized rats evoked a rise in arterial blood pressure at the same dose as used in the present study (17, 18) . The cardio vascular effect of histamine administered i.c.v. seems to be independent of the effect on the adrenal medulla (19) , while the hyperglyce mic effect was produced as a consequence of stimulation of the adrenal medulla (10) . Therefore, the stimulation of the posterior hypothalamus by histamine may not activate the sympathoadrenomedullary axis. The other possibility is that the effect of histamine may be different between conscious freely moving and anesthetized rats. Although we also tested the effect of histamine injected into the lateral septum, medial nucleus of the amyg dala and periaqueductal gray of the midbrain, no significant effect was observed.
From these results, it is concluded that at least the individual brain sites tested by the microinjection of histamine do not play functional roles sufficient to explain the effect of histamine administered i.c.v. The rapid onset of the elevation of plasma catechol amines after the i.c.v. administration of hista mine suggests that the effect of histamine is evoked by the stimulation of plural sites in the brain, located especially in the periventricular region. Moreover, it is possible that the effect of histamine results from the increase in the permeability of brain microvessels rather than the stimulation of a specific neuronal system. However, it cannot be excluded that histamine may affect some brain sites other than those tested in the present experiments.
Further investigations are necessary to determine the locus (loci) of histamine action which induces sympathoadrenomedullary activation.
